YT, H., JS, Y., YM, H., YJ, T., & FJ, L. (2026). Tigecycline-Associated Hypofibrinogenemia and Major Bleeding: Incidence, Predictors, and Clinical Outcomes in a Retrospective Cohort. Infection and drug resistance, 19, 607775. https://doi.org/10.2147/IDR.S607775
Chicago Style (17th ed.) CitationYT, Huang, Yang JS, Huang YM, Tseng YJ, and Lin FJ. "Tigecycline-Associated Hypofibrinogenemia and Major Bleeding: Incidence, Predictors, and Clinical Outcomes in a Retrospective Cohort." Infection and Drug Resistance 19 (2026): 607775. https://doi.org/10.2147/IDR.S607775.
MLA (9th ed.) CitationYT, Huang, et al. "Tigecycline-Associated Hypofibrinogenemia and Major Bleeding: Incidence, Predictors, and Clinical Outcomes in a Retrospective Cohort." Infection and Drug Resistance, vol. 19, 2026, p. 607775, https://doi.org/10.2147/IDR.S607775.